Detalles de la búsqueda
1.
Selinexor in combination with topotecan in patients with advanced or metastatic solid tumors: Results of an open-label, single-center, multi-arm phase Ib study.
Invest New Drugs
; 39(5): 1357-1365, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33909232
2.
Phase I study of nab-paclitaxel, gemcitabine, and bevacizumab in patients with advanced cancers.
Br J Cancer
; 118(11): 1419-1424, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29695765
3.
Phase I study of the combination of crizotinib (as a MET inhibitor) and dasatinib (as a c-SRC inhibitor) in patients with advanced cancer.
Invest New Drugs
; 36(3): 416-423, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29047029
4.
Incidence of infusion reactions to anti-neoplastic agents in early phase clinical trials: The MD Anderson Cancer Center experience.
Invest New Drugs
; 35(1): 59-67, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27687047
5.
Correction to: Selinexor in combination with topotecan in patients with advanced or metastatic solid tumors: Results of an open-label, single-center, multi-arm phase Ib study.
Invest New Drugs
; 40(2): 461, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-34705134
6.
Phase I clinical trial of combination imatinib and ipilimumab in patients with advanced malignancies.
J Immunother Cancer
; 5: 35, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28428884
Resultados
1 -
6
de 6
1
Próxima >
>>